Benefits and risks of prolonged duration dual antiplatelet therapy (clopidogrel and aspirin) after percutaneous coronary intervention in high-risk patients with diabetes mellitus
Wang HY, Cai ZX, Yin D, et al.
Am J Cardiol. 2021;142:14-24
Leggi
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Wang HY, Cai ZX, Yin D, et al.
Am J Cardiol. 2021;142:14-24
Leggi
Escobar C, Barrios V, Cosín J, et al
Diabet Med. 2021;38(3):e14502.
Leggi
Kaikkonen JE, Jula A, Viikari JSA, et al.
J Nutr. 2021;nxaa409
Leggi
Omair M, Koshy AN, Dinh DT, et al.
Am J Cardiol. 2021;142:1-4
Leggi
McGloin H, Devane D, McIntosh CD, et al.
Cochrane Database of Systematic Reviews. Pub. online 8 February 2021
Leggi
Song M
The Lancet Diabetes & Endocrinology. Pub. online 4 February 2021
Leggi
Gregory JM, Slaughter JC, Duffus SH, et al.
Diabetes Care. 2021;44(2):526-532
Leggi
Murphy HR, Howgate C, O’Keefe J, et al.
The Lancet Diabetes & Endocrinology. Pub. online 28 January 2021
Leggi
Pasquel FJ, Lansang MC, Dhatariya K, et al.
The Lancet Diabetes & Endocrinology. Pub. online 27 January 2021
Leggi
Gong IY, Cheung MC, Read S, et al.
Diabetologia. 2021,64:540–551
Leggi